The decision comes after Hershey-based Penn State Health also voluntarily paused the hospital’s liver transplant program in late April.
“We are taking this action while we work with UNOS to review the current organizational structure of our liver and kidney programs,” a spokesperson for Penn State Health said in a statement shared with Becker’s.
The health system is notifying patients on its kidney transplant list of the pause and will provide aid to those who want to switch to other programs or co-list with another program.
Heart, stem cell and bone marrow transplant programs at Penn State Health will remain operational.
“Penn State Health will continue providing post-transplant care for patients who have already received a kidney or liver transplant at Penn State Health,” the statement said. “We continue to work closely with UNOS during this review process, keeping in mind that patients’ needs and safety are our first priority.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
